Jenkins, I. H., Jahanshahi, M., Jueptner, M., Passingham, R. E.
& Brooks, D. J. (2000).
Self-initiated versus externally triggered movements. II. The effect of movement predictability on regional cerebral blood flow.
Brain,
123(6), 1216-1228.
https://doi.org/10.1093/brain/123.6.1216
Botzel, K., Schulze, S., Jahanshahi, M., Jenkins, H., Brown, R. G., Marsden, C. D., Passingham, R. E.
& Brooks, D. J. (1996).
Self-initiated versus externally triggered movements. I. An investigation using measurement of regional cerebral blood flow with PET and movement-related potentials in normal and Parkinson's disease subjects [1].
Brain,
119(3), 1045-1048.
https://doi.org/10.1093/brain/119.3.1045
Jahanshahi, M., Jahanshahi, M., Jenkins, I. H., Brown, R. G., Marsden, C. D., Marsden, C. D., Passingham, R. E.
, Brooks, D. J. & Brooks, D. J. (1995).
Self-initiated versus externally triggered movements: I. An investigation using measurement of regional cerebral blood flow with PET and movement-related potentials in normal and parkinson's disease subjects.
Brain,
118(4), 913-933.
https://doi.org/10.1093/brain/118.4.913
Real, C. C., Binda, K. H., Thomsen, M. B., Lillethorup, T. P., Brooks, D. J. & Landau, A. M. (2023).
Selecting the Best Animal Model of Parkinson's Disease for Your Research Purpose: Insight from in vivo PET Imaging Studies.
Current Neuropharmacology,
21(5), 1241 - 1272.
https://doi.org/10.2174/1570159X21666230216101659
Gilman, S., Wenning, G. K., Low, P. A.
, Brooks, D. J., Mathias, C. J., Trojanowski, J. Q., Wood, N. W., Colosimo, C., Dürr, A., Fowler, C. J., Kaufmann, H., Klockgether, T., Lees, A., Poewe, W., Quinn, N., Revesz, T., Robertson, D., Sandroni, P., Seppi, K. & Vidailhet, M. (2008).
Second consensus statement on the diagnosis of multiple system atrophy.
Neurology,
71(9), 670-676.
https://doi.org/10.1212/01.wnl.0000324625.00404.15
Wang, Y. M., Cai, X. L., Zhang, R. T., Wang, Y., Madsen, K. H.
, Sørensen, T. A., Møller, A., Cheung, E. F. C. & Chan, R. C. K. (2019).
Searchlight classification based on Amplitude of Low Frequency Fluctuation and functional connectivity in individuals with obsessive-compulsive symptoms.
Cognitive Neuropsychiatry,
24(5), 322-334.
https://doi.org/10.1080/13546805.2019.1658575
Rice, C. M., Mallam, E. A., Whone, A. L., Walsh, P.
, Brooks, D. J., Kane, N., Butler, S. R., Marks, D. I. & Scolding, N. J. (2010).
Safey and feasibility of autologous bone marrow cellular therapy in relapsing-progressive multiple sclerosis.
Clinical Pharmacology and Therapeutics,
87(6), 679-685.
https://doi.org/10.1038/clpt.2010.44
Korczyn, A. D.
, Brooks, D. J., Brunt, E. R., Poewe, W. H., Rascol, O. & Stocchi, F. (1998).
Ropinirole versus bromocriptine in the treatment of early Parkinson's disease: A 6-month interim report of a 3-year study.
Movement Disorders,
13(1), 46-51.
https://doi.org/10.1002/mds.870130112
Rascol, O.
, Brooks, D. J., Brunt, E. R., Korczyn, A. D., Poewe, W. H. & Stocchi, F. (1998).
Ropinirole in the treatment of early Parkinson's disease: A 6-month interim report of a 5-year levodopa-controlled study.
Movement Disorders,
13(1), 39-45.
https://doi.org/10.1002/mds.870130111
Boecker, H., Dagher, A., Ceballos-Baumann, A. O., Passingham, R. E., Samuel, M., Friston, K. J., Poline, J. B., Dettmers, C., Conrad, B.
& Brooks, D. J. (1998).
Role of the human rostral supplementary motor area and the basal ganglia in motor sequence control: Investigations with H2 15O PET.
Journal of Neurophysiology,
79(2), 1070-1080.
https://doi.org/10.1152/jn.1998.79.2.1070
Nahimi, A.
, Olsen, A. K., Møller, A., Jakobsen, S., Østergaard, S. D. & Doudet, D. (2007).
Role of monoaminergic innervation in 6-hydroxydopamine unilateral lesioned animal model of Parkinsons Disease and L-DOPA induced dyskinesia. Abstract from OAK Meeting, København, Denmark.
Zhang, Z., Jiang, R., Zhang, C., Williams, B., Jiang, Z., Li, C. T., Chazot, P.
, Pavese, N., Bouridane, A. & Beghdadi, A. (2022).
Robust Brain Age Estimation Based on sMRI via Nonlinear Age-Adaptive Ensemble Learning.
IEEE Transactions on Neural Systems and Rehabilitation Engineering,
30, 2146-2156.
https://doi.org/10.1109/TNSRE.2022.3190467
Yousif, N.
, Pavese, N., Naushahi, M. J., Nandi, D. & Bain, P. G. (2014).
Reversing the polarity of bipolar stimulation in deep brain stimulation for essential tremor: a theoretical explanation for a useful clinical intervention.
Neurocase,
20(1), 10-7.
https://doi.org/10.1080/13554794.2012.713495
Berding, G., Odin, P.
, Brooks, D. J., Nikkhah, G., Matthies, C., Peschel, T., Shing, M., Kolbe, H., van den Hoff, J., Fricke, H., Dengler, R., Samii, M. & Knapp, W. H. (2001).
Resting regional cerebral glucose metabolism in advanced Parkinson's disease studied in the off and on conditions with [18F]FDG-PET.
Movement Disorders,
16(6), 1014-1022.
https://doi.org/10.1002/mds.1212
Piccini, P.
, Pavese, N., Hagell, P., Reimer, J., Bjorklund, A., Oertel, W. H., Quinn, N. P.
, Brooks, D. J. & Lindvall, O. (2006).
Reply: Rate of progression determines the clinical outcome after neural transplantation in Parkinson's disease [2].
Brain,
129(7).
https://doi.org/10.1093/brain/awl113
Kew, J. J. M., Ridding, M. C., Rothwell, J. C., Passingham, R. E., Leigh, P. N., Sooriakumaran, S., Frackowiak, R. S. J.
& Brooks, D. J. (1994).
Reorganization of cortical blood flow and transcranial magnetic stimulation maps in human subjects after upper limb amputation.
Journal of Neurophysiology,
72(5), 2517-2524.
https://doi.org/10.1152/jn.1994.72.5.2517
O’Brien, J. T., Chouliaras, L., Sultana, J., Taylor, J. P., Ballard, C. & on behalf of the RENEWAL Study Group (2022).
RENEWAL: REpurposing study to find NEW compounds with Activity for Lewy body dementia—an international Delphi consensus.
Alzheimer's Research and Therapy,
14(1), Article 169.
https://doi.org/10.1186/s13195-022-01103-7
Lundby, L.
, Møller, A., Buntzen, S.
, Krogh, K., Vang, K.
, Gjedde, A. & Laurberg, S. (2011).
Relief of fecal incontinence by sacral nerve stimulation linked to focal brain activation.
Diseases of the Colon & Rectum,
54(3), 318-23.
https://doi.org/10.1007/DCR.0b013e31820348ac
Lundby, L.
, Møller, A., Buntzen, S., Hansen, K. V.
, Gjedde, A. & Laurberg, S. (2011).
Relief of faecal incontinence by sacral nerve stimulation linked to focal brain.
Diseases of the Colon & Rectum,
54(3), 318-323.
Abrahams, S., Goldstein, L. H., Al-Chalabi, A., Pickering, A., Morris, R. G., Passingham, R. E.
, Brooks, D. J. & Leigh, P. N. (1997).
Relation between cognitive dysfunction and pseudobulbar palsy in amyotrophic lateral sclerosis.
Journal of Neurology Neurosurgery and Psychiatry,
62(5), 464-472.
https://doi.org/10.1136/jnnp.62.5.464
Dettmers, C., Fink, G. R., Lemon, R. N., Stephan, K. M., Passingham, R. E., Silbersweig, D., Holmes, A., Ridding, M. C.
, Brooks, D. J. & Frackowiak, R. S. J. (1995).
Relation between cerebral activity and force in the motor areas of the human brain.
Journal of Neurophysiology,
74(2), 802-815.
https://doi.org/10.1152/jn.1995.74.2.802
Olesen, S.-P.
, Møller, A., Mordvintcev, P. I., Busse, R. & Mülsch, A. (1997).
Regional measurements of NO formed in vivo during brain ischemia.
Acta Neurologica Scandinavica,
95, 219-224.
Doppler, C. E. J.
, Kinnerup, M. B., Brune, C., Farrher, E., Betts, M.
, Fedorova, T. D., Schaldemose, J. L.
, Knudsen, K., Ismail, R., Seger, A. D.
, Hansen, A. K., Stær, K., Fink, G. R.
, Brooks, D. J., Nahimi, A., Borghammer, P. & Sommerauer, M. (2021).
Regional locus coeruleus degeneration is uncoupled from noradrenergic terminal loss in Parkinson's disease.
Brain : a journal of neurology,
144(9), 2732–2744.
https://doi.org/10.1093/brain/awab236
Koepp, M. J., Labbé, C., Richardson, M. P.
, Brooks, D. J., Van Paesschen, W., Cunningham, V. J. & Duncan, J. S. (1997).
Regional hippocampal [11C]flumazenil PET in temporal lobe epilepsy with unilateral and bilateral hippocampal sclerosis.
Brain,
120(10), 1865-1876.
https://doi.org/10.1093/brain/120.10.1865
Brooks, D. J., Gibbs, J. S. R., Sharp, P., Herold, S., Turton, D. R., Luthra, S. K., Kohner, E. M., Bloom, S. R. & Jones, T. (1986).
Regional cerebral glucose transport in insulin-dependent diabetic patients studied using [11C]3-O-methyl-D-glucose and positron emission tomography.
Journal of Cerebral Blood Flow and Metabolism,
6(2), 240-244.
https://doi.org/10.1038/jcbfm.1986.37
Ikoma, Y., Edison, P., Ramlackhansingh, A.
, Brooks, D. J. & Turkheimer, F. E. (2013).
Reference region automatic extraction in dynamic [(11)C]PIB.
Journal of Cerebral Blood Flow and Metabolism,
33(11), 1725-31.
https://doi.org/10.1038/jcbfm.2013.133
Turkheimer, F. E., Edison, P.
, Pavese, N., Roncaroli, F., Anderson, A. N., Hammers, A., Gerhard, A., Hinz, R., Tai, Y. F.
& Brooks, D. J. (2007).
Reference and target region modeling of [11C]-(R)-PK11195 brain studies.
Journal of Nuclear Medicine,
48(1), 158-167.
Andersen, K. B., Hansen, A. K., Damholdt, M. F., Horsager, J., Skjaerbaek, C., Gottrup, H., Klit, H.
, Schacht, A. C., Danielsen, E. H., Brooks, D. J. & Borghammer, P. (2021).
Reduced Synaptic Density in Patients with Lewy Body Dementia: An [11C-]UCB-J PET Imaging Study.
Movement Disorders,
36(9), 2057-2065.
https://doi.org/10.1002/mds.28617
Elmholdt, E.-M.
, Skewes, J. C., Dietz, M., Møller, A., Jensen, M. S., Roepstorff, A., Wiech, K.
& Staehelin-Jensen, T. (2017).
Reduced Pain Sensation and Reduced BOLD Signal in Parietofrontal Networks during Religious Prayer.
Frontiers in Human Neuroscience,
11, Article 337.
https://doi.org/10.3389/fnhum.2017.00337
Rascol, O.
, Brooks, D. J., Melamed, E., Oertel, W., Poewe, W., Stocchi, F. & Tolosa, E. (2005).
Rasagiline as an adjunct to levodopa in patients with Parkinson's disease and motor fluctuations (LARGO, Lasting effect in Adjunct therapy with Rasagiline Given Once daily, study): A randomised, double-blind, parallel-group trial.
Lancet,
365(9463), 947-954.
https://doi.org/10.1016/S0140-6736(05)71083-7
Lang, A. E., Gill, S., Patel, N. K., Lozano, A., Nutt, J. G., Penn, R.
, Brooks, D. J., Hotton, G., Moro, E., Heywood, P., Brodsky, M. A., Burchiel, K., Kelly, P., Dalvi, A., Scott, B., Stacy, M., Turner, D., Wooten, V. G. F., Elias, W. J. ... Traub, M. (2006).
Randomized controlled trial of intraputamenal glial cell line-derived neurotrophic factor infusion in Parkinson disease.
Annals of Neurology,
59(3), 459-466.
https://doi.org/10.1002/ana.20737
Gillies, J., Luthra, S. K., Brady, F., Karasawa, A., Shimada, J., Kase, H.
& Brooks, D. J. (1999).
Radiolabelling of KW-6002 with [11C]iodomethane for studies of the adenosine A(2A) receptor in vivo.
Journal of Labelled Compounds and Radiopharmaceuticals,
42(SUPPL. 1).
Dall, A. M., Danielsen, E. H., Sørensen, J. C., Andersen, F.
, Møller, A., Zimmer, J., Gjedde, A., the DaNeX Group & Cumming, P. (2002).
Quantitative [18F]Fluorodopa/PET and histology of fetal mesencephalic dopaminergic grafts to the striatum of MPTP-poisoned Minipigs.
Cell Transplantation,
11, 733-746.
Brooks, D. J., Beaney, R. P., Lammertsma, A. A., Leenders, K. L., Horlock, P. L., Kensett, M. J., Marshall, J., Thomas, D. G. & Jones, T. (1984).
Quantitative measurement of blood-brain barrier permeability using rubidium-82 and positron emission tomography.
Journal of Cerebral Blood Flow and Metabolism,
4(4), 535-545.
https://doi.org/10.1038/jcbfm.1984.78
Steinmüller, J. B., Binda, K. H., Lillethorup, T. P., Søgaard, B., Orlowski, D., Landau, A. M., Bjarkam, C. R.
, Sørensen, J. C. H. & Glud, A. N. (2022).
Quantitative assessment of motor function in minipig models of neurological disorders using a pressure-sensitive gait mat.
Journal of Neuroscience Methods,
380, Article 109678.
https://doi.org/10.1016/j.jneumeth.2022.109678
Dall, A. M.
, Danielsen, E. H., Sørensen, J. C. H., Andersen, F.
, Møller, A., Zimmer, J.
, Gjedde, A. H. & Cumming, P. (2002).
Quantitative [18F]fluorodopa/PET and histology of fetal mesencephalic dopaminergic grafts to the striatum of MPTP-poisoned minipigs. Cell Transplantation,
11(8), 733-46.
McGinnity, C. J., Shidahara, M., Feldmann, M., Keihaninejad, S., Riaño Barros, D. A., Gousias, I. S., Duncan, J. S.
, Brooks, D. J., Heckemann, R. A., Turkheimer, F. E., Hammers, A. & Koepp, M. J. (2013).
Quantification of opioid receptor availability following spontaneous epileptic seizures: correction of [11C]diprenorphine PET data for the partial-volume effect.
NeuroImage,
79, 72-80.
https://doi.org/10.1016/j.neuroimage.2013.04.015
McGinnity, C. J., Hammers, A., Barros, D. A. R., Luthra, S. K., Jones, M. P. A., Trigg, W., Symms, M. R.
, Brooks, D. J., Koepp, M. J. & Duncan, J. S. (2012).
Quantification of activated NMDA receptors with [F-18]GE-179 PET.
Journal of Cerebral Blood Flow and Metabolism,
32, S124-S125.
Phan, J.-A., Landau, A. M., Wong, D. F.
, Jakobsen, S., Nahimi, A., Doudet, D. J.
& Gjedde, A. (2015).
Quantification of [(11)C]yohimbine binding to α2 adrenoceptors in rat brain in vivo.
Journal of Cerebral Blood Flow and Metabolism,
35(3), 501-511.
https://doi.org/10.1038/jcbfm.2014.225
Taylor-Robinson, S. D., Weeks, R. A., Bryant, D. J., Sargentoni, J., Marcus, C. D., Harding, A. E.
& Brooks, D. J. (1996).
Proton magnetic resonance spectroscopy in Huntington's disease: Evidence in favour of the glutamate excitotoxic theory? Movement Disorders,
11(2), 167-173.
https://doi.org/10.1002/mds.870110209
Glud, A. N., Lillethorup, T. P., Landeck, N.
, Alstrup, A. K. O., Johnsen, E. L., Brooks, D., Kirik, D., Bjarkam, C.
, Landau, A. M. & Sørensen, J. C. H. (2016).
PROTEIN AGREGATION MODELS OF PARKINSONS DISEASE USING VIRAL VECTORS, PROTEASOME INHIBITION AND INOCULATION OF PREFORMED FIBRILS IN THE GOTTINGEN MINIPIG CNS. Poster session presented at Aarhus University Graduate School of Health, PhD Day 2016: set science free, Denmark.
Chadi, G.
, Møller, A., Rosén, L., Janson, A. M., Agnati, L. A., Goldstein, M., Ögren, S.-O., Pettersson, R. F. & Fuxe, K. (1993).
Protective actions of human recombinant basic fibroblast growth factor on MPTP-lesioned nigrostriatal dopamine neurons after intraventricular infusion.
Experimental Brain Research,
97, 145-158.
Landau, A. M., Jakobsen, S., Alstrup, A. K. O., Schacht, A. C.
, Møller, A., Sørensen, J. C. H. & Doudet, D. (2013).
Proteasome inhibition model of Parkinson’s disease in Gottingen minipig: Combined dopaminergic and noradrenergic effects. Abstract from The XXVIth International Symposium on Cerebral Blood Flow, Metabolism and Function & XIth International Conference on Quantification of Brain Function with PET, Shanghai, China.
Stuart, S., Lawson, R. A., Yarnall, A. J., Nell, J., Alcock, L., Duncan, G. W., Khoo, T. K., Barker, R. A., Rochester, L., Burn, D. J. & ICICLE-PD Study Grp (2019).
Pro-Saccades Predict Cognitive Decline in Parkinson's Disease: ICICLE-PD.
Movement Disorders,
34(11), 1690-1698.
https://doi.org/10.1002/mds.27813
Pavese, N., Andrews, T. C.
, Brooks, D. J., Ho, A. K., Rosser, A. E., Barker, R. A., Robbins, T. W., Sahakian, B. J., Dunnett, S. B. & Piccini, P. (2003).
Progressive striatal and cortical dopamine receptor dysfunction in Huntington's disease: A pet study.
Brain,
126(5), 1127-1135.
https://doi.org/10.1093/brain/awg119
Pasquini, J., Ceravolo, R.
, Brooks, D. J., Bonuccelli, U.
& Pavese, N. (2020).
Progressive loss of raphe nuclei serotonin transporter in early Parkinson's disease: A longitudinal 123I-FP-CIT SPECT study.
Parkinsonism & Related Disorders,
77, 170-175.
https://doi.org/10.1016/j.parkreldis.2019.03.025
Pasquini, J., Ceravolo, R., Qamhawi, Z., Lee, J.-Y., Deuschl, G.
, Brooks, D. J., Bonuccelli, U.
& Pavese, N. (2018).
Progression of tremor in early stages of Parkinson's disease: a clinical and neuroimaging study.
Brain,
141(3), 811-821.
https://doi.org/10.1093/brain/awx376
Xu, Z., Anderson, K. N., Saffari, S. E., Lawson, R. A., Chaudhuri, K. R.
, Brooks, D. & Pavese, N. (2021).
Progression of sleep disturbances in Parkinson's disease: a 5-year longitudinal study.
Journal of Neurology,
268(1), 312-320.
https://doi.org/10.1007/s00415-020-10140-x
Xu, Z., Anderson, K., Lawson, R.
, Brooks, D. J. & Pavese, N. (2018).
Progression of sleep disorders spectrum in Parkinson's Disease: A 5 year clinical longitudinal study.
Movement Disorders,
33, S761-S762.
Taylor, S., Gafton, J., Shah, B., Pagano, G., Chaudhuri, K. R.
, Brooks, D. J. & Pavese, N. (2016).
Progression of nonmotor symptoms in subgroups of patients with non-dopamine-deficient Parkinsonism.
Movement Disorders,
31(3), 344-51.
https://doi.org/10.1002/mds.26456
Khan, N. L.
, Brooks, D. J., Pavese, N., Sweeney, M. G., Wood, N. W., Lees, A. J. & Piccini, P. (2002).
Progression of nigrostriatal dysfunction in a parkin kindred: An [18F]dopa PET and clinical study.
Brain,
125(10), 2248-2256.
Pavese, N., Rivero-Bosch, M., Lewis, S. J., Whone, A. L.
& Brooks, D. J. (2011).
Progression of monoaminergic dysfunction in Parkinson's disease: a longitudinal 18F-dopa PET study.
NeuroImage,
56(3), 1463-8.
https://doi.org/10.1016/j.neuroimage.2011.03.012
Staer, K., Iranzo, A.
, Terkelsen, M. H., Stokholm, M. G., Danielsen, E. H., Østergaard, K., Serradell, M.
, Otto, M., Svendsen, K. B., Garrido, A., Vilas, D., Santamaria, J., Møller, A., Gaig, C.
, Brooks, D. J., Borghammer, P., Tolosa, E.
& Pavese, N. (2024).
Progression of brain cholinergic dysfunction in patients with isolated rapid eye movement sleep behavior disorder.
European Journal of Neurology,
31(1), Article e16101.
https://doi.org/10.1111/ene.16101
Wilkinson, L., Tai, Y. F., Lin, C. S., Lagnado, D. A.
, Brooks, D. J., Piccini, P. & Jahanshahi, M. (2014).
Probabilistic classification learning with corrective feedback is associated with in vivo striatal dopamine release in the ventral striatum, while learning without feedback is not.
Human Brain Mapping,
35(10), 5106-15.
https://doi.org/10.1002/hbm.22536
Jiang, R., Chazot, P.
, Pavese, N., Crookes, D., Bouridane, A. & Celebi, M. E. (2022).
Private Facial Prediagnosis as an Edge Service for Parkinson's DBS Treatment Valuation.
IEEE Journal of Biomedical and Health Informatics,
26(6), 2703-2713.
https://doi.org/10.1109/JBHI.2022.3146369
Mattsson, N., Groot, C., Jansen, W. J., Landau, S. M., Villemagne, V. L., Engelborghs, S., Mintun, M. M., Lleo, A., Molinuevo, J. L., Jagust, W. J., Frisoni, G. B., Ivanoiu, A., Chételat, G., Resende de Oliveira, C., Rodrigue, K. M., Kornhuber, J., Wallin, A., Klimkowicz-Mrowiec, A., Kandimalla, R. ... Ossenkoppele, R. (2018).
Prevalence of the apolipoprotein E ε4 allele in amyloid β positive subjects across the spectrum of Alzheimer's disease.
Alzheimer's & Dementia,
14(7), 913-924.
https://doi.org/10.1016/j.jalz.2018.02.009
Marazziti, D., Toni, C., Pedri, S., Bonuccelli, U.
, Pavese, N., Lucetti, C., Nuti, A., Muratorio, A. & Cassano, G. B. (1999).
Prevalence of headache syndromes in panic disorder.
International Clinical Psychopharmacology,
14(4), 247-251.
https://doi.org/10.1097/00004850-199907000-00007
Jansen, W. J., Janssen, O., Tijms, B. M., Vos, S. J. B., Ossenkoppele, R., Visser, P. J. & Amyloid Biomarker Study Group (2022).
Prevalence Estimates of Amyloid Abnormality Across the Alzheimer Disease Clinical Spectrum.
JAMA Neurology,
79(3), 228-243.
https://doi.org/10.1001/jamaneurol.2021.5216
Hvingelby, V. S., Terkelsen, M. H., Valdemarsen, R. N., Andersen, A. S. M., Danielsen, E. H., Møller, M.
, Pavese, N. & Johnsen, E. (2023).
Prevalence and severity of freezing of gait in a Danish cohort of people with Parkinsonʼs disease.
Danish Medical Journal,
70(12), Article A03230209.
https://ugeskriftet.dk/dmj/prevalence-and-severity-freezing-gait-danish-cohort-people-parkinsons-disease
Hvingelby, V., Terkelsen, M. H., Valdemarsen, R. N., Andersen, A. S. M., Danielsen, E. H., Møller, M.
, Pavese, N. & Johnsen, E. L. (2023).
Prevalence and severity of freezing of gait in a Danish cohort of people with Parkinson’s disease.
Danish Medical Journal,
70(12), Article A03230209.
McDonald, C., Lawson, R. A., Duncan, G. W., Khoo, T. K.
, Brooks, D. J., Barker, R. A., Yarnall, A. J. & Burn, D. J. (2016).
Prevalence and risk factors for orthostatic hypotension in early PD.
Movement Disorders,
31, S120-S120.
Durcan, R., Wiblin, L., Lawson, R. A., Khoo, T. K., Yarnall, A. J., Duncan, G. W.
, Brooks, D. J., Pavese, N., Burn, D. J. & ICICLE-PD Study Group (2019).
Prevalence and duration of non-motor symptoms in prodromal Parkinson's disease.
European Journal of Neurology,
26(7), 979-985.
https://doi.org/10.1111/ene.13919
Kinnerup, M. B., Sommerauer, M.
, Damholdt, M. F., Schaldemose, J. L.
, Ismail, R., Terkelsen, A. J., Stær, K.
, Hansen, A., Fedorova, T. D., Knudsen, K., Skjærbæk, C., Borghammer, P., Pavese, N., Brooks, D. J. & Nahimi, A. (2021).
Preserved noradrenergic function in Parkinson's disease patients with rest tremor.
Neurobiology of Disease,
152, Article 105295.
https://doi.org/10.1016/j.nbd.2021.105295
Sabers, A., a´Rogvi-Hansen, B., Dam, M., Fischer-Rasmussen, W., Gram, L., Hansen, M.
, Møller, A. & Winkel, H. (1998).
Pregnancy and epilepsy: a retrospective study of 151 pregnancies.
Acta Neurologica Scandinavica,
97, 164-170.
Kirkeby, A., Nelander, J., Hoban, D. B., Rogelius, N., Bjartmarz, H., Novo Nordisk Cell Therapy R&D, Storm, P., Fiorenzano, A., Adler, A. F., Vale, S., Mudannayake, J., Zhang, Y., Cardoso, T., Mattsson, B.
, Landau, A. M., Glud, A. N., Sørensen, J. C., Lillethorup, T. P., Lowdell, M. ... Parmar, M. (2023).
Preclinical quality, safety, and efficacy of a human embryonic stem cell-derived product for the treatment of Parkinson's disease, STEM-PD.
Cell Stem Cell,
30(10), 1299-1314.e9.
https://doi.org/10.1016/j.stem.2023.08.014
Thomsen, M. B., Schacht, A. C., Alstrup, A. K. O., Jacobsen, J., Lillethorup, T. P., Bærentzen, S. L., Noer, O., Orlowski, D., Elfving, B., Müller, H. K., Brooks, D. J. & Landau, A. M. (2020).
Preclinical PET Studies of [11C]UCB-J Binding in Minipig Brain.
Molecular Imaging and Biology,
22(5), 1290-1300.
https://doi.org/10.1007/s11307-020-01506-8
Vibholm, A. K.
, Landau, A. M., Winterdahl, M., Jakobsen, S., Alstrup, A. K. O., Simonsen, M.
, Bender, D., Møller, A.
, Pavese, N., Sørensen, J. C. H. & Brooks, D. (2015).
Preclinical in-vivo imaging of activated NMDA receptor ion channels with the novel radioligand 18F-GE179. Abstract from Pd.d.-dag, Aarhus, Denmark.
Jegindø, E.-M. E., Skewes, J., Wiech, K.
, Lund, T. E., Jensen, M. S., Møller, A., Geertz, A. W., Roepstorff, A. & Jensen, T. S. (2012).
Prayer and Pain: an fMRI study of Prefrontal Control and Opioidergic Pain Modulation During Prayer. Poster session presented at IASP 14th World Congress on Pain, Milano, Italy.
Marazziti, D., Bonuccelli, U., Nuti, A., Toni, C., Pedri, S., Palego, L.
, Pavese, N., Lucetti, C., Muratorio, A. & Cassano, GB. (1994).
Platelet 3H‐imipramine binding and sulphotransferase activity in primary headache.
Cephalalgia,
14(3), 210-214.
https://doi.org/10.1046/j.1468-2982.1994.014003210.x
Fast, R., Rodell, A., Gjedde, A.
, Mouridsen, K., Alstrup, A. K. O., Bjarkam, C. R., West, M. J., Berendt, M.
& Møller, A. (2013).
PiB fails to map amyloid deposits in cerebral cortex of aged dogs with canine cognitive dysfunction.
Frontiers in Aging Neuroscience,
5(99), 1-11.
Andersen, B. B.
, Møller, A., Gram, L., Jensen, N. O. & Dam, M. (1992).
Phenytoin-loading: pharmacokinetic comparison between an intravenous bolus injection and a diluted standard solution.
Acta Neurology Scand,
85, 174-176.
Nelissen, N., Van Laere, K., Thurfjell, L., Owenius, R., Vandenbulcke, M., Koole, M., Bormans, G.
, Brooks, D. J. & Vandenberghe, R. (2009).
Phase 1 study of the Pittsburgh compound B derivative18F- flutemetamol in healthy volunteers and patients with probable Alzheimer disease.
Journal of Nuclear Medicine,
50(8), 1251-1259.
https://doi.org/10.2967/jnumed.109.063305
Campbell-Meiklejohn, D.
, Simonsen, A., Jensen, M., Wohlert, V., Gjerløff, T., Scheel-Krüger, J.
, Møller, A., Frith, C. D.
& Roepstorff, A. (2011).
Pharmacology of social conformity: A role for catecholamines. Poster session presented at Neuroscience.
Campbell-Meiklejohn, D., Scheel-Krüger, J.
, Simonsen, A., Jensen, M., Gjerløff, T.
, Roepstorff, A., Møller, A. & Frith, C. D. (2011).
Pharmacology of social conformity. Poster session presented at The Social Brain, Cambridge, United Kingdom.
Møller, A., Christophersen, P., Drejer, J., Axelsson, O., Peters, D., Jensen, L. H. & Nielsen, E. Ø. (1995).
Pharmacological profile and anti-ischemic properties of the Ca2+-channel blocker NS-638.
Neurology Res.,
17, 353-360.
Brooks, D. J., Turjanski, N., Sawle, G. V., Playford, E. D. & Lees, A. J. (1992).
PET studies on the integrity of the pre and postsynaptic dopaminergic system in Tourette syndrome. Advances in neurology,
58, 227-231.
Turjanski, N., Sawle, G. V., Playford, E. D., Weeks, R., Lammerstma, A. A., Lees, A. J.
& Brooks, D. J. (1994).
PET studies of the presynaptic and postsynaptic dopaminergic system in Tourette's syndrome.
Journal of Neurology Neurosurgery and Psychiatry,
57(6), 688-692.
https://doi.org/10.1136/jnnp.57.6.688
Landau, A. M., Wegener, G., Jakobsen, S., Orlowski, D., Thomsen, M., Schacht, A. C.
, Alstrup, A. K. O., Jacobsen, J., Mørk, A.
, Sørensen, J. C. H. & Doudet, D. J. (2017).
PET-microdialysis study of noradrenaline release in pig brain. Poster session presented at Psykiatriens 12. forskningsdag, Aarhus, Denmark.
Landau, A. M., Møller, A., Winterdahl, M., Alstrup, A. K. O., Jakobsen, S., Schacht, A. C.
, Bender, D., Scheel-Krüger, J.
& Kringelbach, M. L. (2013).
PET Imaging Sugar Addiction in Minipigs. Poster session presented at Scandinavian College of Neuropsychopharmacology, København, Denmark.
Thomsen, M. B., Ferreira, S. A., Schacht, A. C., Jacobsen, J., Simonsen, M., Betzer, C., Jensen, P. H., Brooks, D. J., Landau, A. M. & Romero-Ramos, M. (2021).
PET imaging reveals early and progressive dopaminergic deficits after intra-striatal injection of preformed alpha-synuclein fibrils in rats.
Neurobiology of Disease,
149, Article 105229.
https://doi.org/10.1016/j.nbd.2020.105229
Landau, A. M., Møller, A., Winterdahl, M., Jakobsen, S., Alstrup, A. K. O., Schacht, A.
, Bender, D., Scheel-Krüger, J.
& Kringelbach, M. L. (2013).
PET imaging of sugar addiction in minipigs: Effects on the dopamine D2/3 receptor. Poster session presented at The XXVIth International Symposium on Cerebral Blood Flow, Metabolism and Function & XIth International Conference on Quantification of Brain Function with PET, Shanghai, China.
Boecker, H., Ceballos-Baumann, A. O., Bartenstein, P., Siebner, H. R., Forster, K., Dagher, A., Haslinger, B.
, Brooks, D. J. & Conrad, B. (1999).
PET imaging of motor sequence control: Pure motor imagination of increasingly complex finger sequences, A parametric 3D H2
15O PET study.
NeuroImage,
9(6 PART II).
Turkheimer, F. E., Boussion, N., Anderson, A. N.
, Pavese, N., Piccini, P. & Visvikis, D. (2008).
PET image denoising using a synergistic multiresolution analysis of structural (MRI/CT) and functional datasets.
Journal of Nuclear Medicine,
49(4), 657-666.
https://doi.org/10.2967/jnumed.107.041871
Turkheimer, F. E., Anderson, A. N., Boussion, N.
, Pavese, N., Brooks, D. J. & Visvikis, D. (2007).
PET image denoising through a synergistic wavelet transform based multi-resolution analysis of structural and functional datasets.
Journal of Cerebral Blood Flow and Metabolism,
27(SUPPL. 1).
Ghadery, C., Best, L. A.
, Pavese, N., Tai, Y. F. & Strafella, A. P. (2019).
PET Evaluation of Microglial Activation in Non-neurodegenerative Brain Diseases.
Current Neurology and Neuroscience Reports,
19(7), Article 38.
https://doi.org/10.1007/s11910-019-0951-x
Winterdahl, M., Audrain, H., Landau, A. M., Smith, D. F., Bonaventure, P., Shoblock, J. R., Carruthers, N., Swanson, D.
& Bender, D. (2014).
PET brain imaging of neuropeptide Y2 receptors using N-11C-methyl-JNJ-31020028 in pigs.
Journal of Nuclear Medicine,
55(4), 635-9.
https://doi.org/10.2967/jnumed.113.125351
Vuust, P., Josefsen, L. G.
, Hansen, N. C., Ramsgaard, S.
, Møller, A. & Linnet, J. (2010).
Personality influences career choice: Sensation seeking in professional musicians.
Music Education Research,
12(2), 219.
https://doi.org/10.1080/14613801003746584
Tai, Y. F., Hoshi, R., Brignell, C. M., Cohen, L.
, Brooks, D. J., Curran, H. V. & Piccini, P. (2011).
Persistent nigrostriatal dopaminergic abnormalities in ex-users of MDMA (ecstasy): An 18F-dopa PET Study.
Neuropsychopharmacology,
36(4), 735-743.
https://doi.org/10.1038/npp.2010.201
Pavese, N., Giannaccini, G., Betti, L., Ferrari, S., Bonanni, E., Bonuccelli, U., Murri, L. & Lucacchini, A. (2000).
Peripheral-type benzodiazepine receptors in human blood cells of patients affected by migraine without aura.
Neurochemistry International,
37(4), 363-368.
https://doi.org/10.1016/S0197-0186(00)00039-5
Kjeldsen, P. L., Damholdt, M. F., Madsen, L. S., Nissen, P. H., Aanerud, J. F. A., Parbo, P., Ismail, R.
, Thomsen, M. K., Eskildsen, S. F., Østergaard, L. & Brooks, D. J. (2024).
Performance on complex memory tests is associated with β-amyloid in individuals at risk of developing Alzheimer's disease.
Journal of Neuropsychology,
18(1), 120-135. Article JNP12332.
https://doi.org/10.1111/jnp.12332
Arjmand, S., Bender, D., Jakobsen, S., Wegener, G. & Landau, A. M. (2023).
Peering into the Brain's Estrogen Receptors: PET Tracers for Visualization of Nuclear and Extranuclear Estrogen Receptors in Brain Disorders.
Biomolecules,
13(9), Article 1405.
https://doi.org/10.3390/biom13091405
Thevathasan, W., Debu, B., Aziz, T., Bloem, B. R., Blahak, C., Butson, C., Czernecki, V., Foltynie, T., Fraix, V., Grabli, D., Joint, C., Lozano, A. M., Okun, M. S., Ostrem, J.
, Pavese, N., Schrader, C., Tai, C.-H., Krauss, J. K., Moro, E. & Movement Disorders Society PPN DBS Working Groupin collaboration with the World Society for Stereotactic and Functional Neurosurgery (2018).
Pedunculopontine nucleus deep brain stimulation in Parkinson's disease: A clinical review.
Movement Disorders,
33(1), 10-20.
https://doi.org/10.1002/mds.27098
Khan, A. N., Bronstein, A., Bain, P.
, Pavese, N. & Nandi, D. (2019).
Pedunculopontine and Subthalamic Nucleus Stimulation Effect on Saccades in Parkinson Disease.
World Neurosurgery,
126, e219-e231.
https://doi.org/10.1016/j.wneu.2019.02.014
Dai, W., Zhou, H.
, Møller, A., Wei, P., Hu, K., Feng, K., Han, J., Li, Q. & Liu, X. (2022).
Patients with Methamphetamine Use Disorder Show Highly Utilized Proactive Inhibitory Control and Intact Reactive Inhibitory Control with Long-Term Abstinence.
Brain sciences,
12(8), Article 974.
https://doi.org/10.3390/brainsci12080974
Callesen, M. B., Linnet, J.
, Thomsen, K. R., Gjedde, A. & Møller, A. (2008).
Pathological Gambling in Parkinson's Disease. Abstract from Seventh Annual OAK Meeting for Danish Brain Research Laboratories, Odense, Denmark.
Peterson, E.
, Møller, A., Doudet, D., Bailey, C., Hansen, K. V., Rodell, A., Linnet, J.
& Gjedde, A. (2010).
Pathological gambling: relation of skin conductance response to dopaminergic neurotransmission and sensation-seeking .
European Neuropsychopharmacology,
20(11), 766-75.
Obeso, J. A., Stamelou, M., Goetz, C. G., Poewe, W., Lang, A. E., Weintraub, D., Burn, D., Halliday, G. M., Bezard, E., Przedborski, S., Lehericy, S.
, Brooks, D. J., Rothwell, J. C., Hallett, M., DeLong, M. R., Marras, C., Tanner, C. M., Ross, G. W., Langston, J. W. ... Stoessl, A. J. (2017).
Past, present, and future of Parkinson's disease: A special essay on the 200th Anniversary of the Shaking Palsy.
Movement Disorders,
32(9), 1264-1310.
https://doi.org/10.1002/mds.27115
Jenner, P., Morris, H. R., Robbins, T. W., Goedert, M., Hardy, J., Ben-Shlomo, Y., Bolam, P., Burn, D., Hindle, J. V.
& Brooks, D. (2013).
Parkinson's disease--the debate on the clinical phenomenology, aetiology, pathology and pathogenesis.
Journal of Parkinson's Disease,
3(1), 1-11.
https://doi.org/10.3233/JPD-130175
Glud, A. N., Landau, A. M.
, Lillethorup, T. P., Landeck, N.
, Johnsen, E. L., Bjarkam, C. R.
, Brooks, D., Kirik, D.
& Sørensen, J. C. H. (2015).
PARKINSON’S DISEASE MODELS OF ABNORMAL PROTEIN AGGREGATION IN THE GOTTINGEN MINIPIG CNS.
Glud, A. N., Landau, A. M., Lillethorup, T. P., Landeck, N.
, Johnsen, E. L., Alstrup, A. K. O., Bjarkam, C. R.
, Brooks, D., Kirik, D.
& Sørensen, J. C. H. (2015).
PARKINSON’S DISEASE MODELS OF ABNORMAL PROTEIN AGGREGATION IN THE GOTTINGEN MINIPIG CNS: Brain Prize Meeting 2015.
Fan, Z., Dani, M., Femminella, G. D., Wood, M., Calsolaro, V., Veronese, M., Turkheimer, F., Gentleman, S.
, Brooks, D. J., Hinz, R. & Edison, P. (2018).
Parametric mapping using spectral analysis for C-11-PBR28 PET reveals neuroinflammation in mild cognitive impairment subjects.
European Journal of Nuclear Medicine and Molecular Imaging,
45(8), 1432-1441.
https://doi.org/10.1007/s00259-018-3984-5
Samuel, M., Ceballos-Baumann, A. O., Turjanski, N., Boecker, H., Gorospe, A., Linazasoro, G., Holmes, A. P., DeLong, M. R., Vitek, J. L., Thomas, D. G. T., Quinn, N. P., Obeso, J. A.
& Brooks, D. J. (1997).
Pallidotomy in Parkinson's disease increases supplementary motor area and prefrontal activation during performance of volitional movements An H2 15O PET study.
Brain,
120(8), 1301-1313.
https://doi.org/10.1093/brain/120.8.1301
Lee, J. Y., Lao-Kaim, N. P., Pasquini, J., Deuschl, G.
, Pavese, N. & Piccini, P. (2018).
Pallidal dopaminergic denervation and rest tremor in early Parkinson's disease: PPMI cohort analysis.
Parkinsonism and Related Disorders,
51, 101-104.
https://doi.org/10.1016/j.parkreldis.2018.02.039
Jegindø, E.-M. E., Skewes, J., Wiech, K.
, Lund, T. E., Jensen, M. S., Møller, A., Geertz, A. W., Roepstorff, A. & Jensen, T. S. (2012).
Pain reduction from prayer is associated with BOLD decrease in attentional and executive networks. Poster session presented at Society for Neuroscience 2012, New Orleans, United States.
Maxan, A., Mason, S., Saint-Pierre, M., Smith, E., Ho, A., Harrower, T., Watts, C., Tai, Y.
, Pavese, N., Savage, J. C., Tremblay, M.-È., Gould, P., Rosser, A. E., Dunnett, S. B., Piccini, P., Barker, R. A. & Cicchetti, F. (2018).
Outcome of cell suspension allografts in a patient with Huntington's disease.
Annals of Neurology,
84(6), 950-956.
https://doi.org/10.1002/ana.25354
Varming, T., Sager, T. N., Mathiesen, C., Johansen, T. H.
, Møller, A., Wätjen, F. & Drejer, J. (2001).
Optimazation of isatine oximes as neuroprotective AMPA receptor antagonist: In vitro and in vivo evaluation of SPD 502. In: Excitatory amino acids: Ten years after.
IOS press.
Whone, A. L., Von Spiczak, S., Edwards, M., Valente, E. M., Hammers, A., Bhatia, K. P.
& Brooks, D. J. (2004).
Opioid binding in DYT1 primary torsion dystonia: An 11C-diprenorphine PET study.
Movement Disorders,
19(12), 1498-1503.
https://doi.org/10.1002/mds.20238
Schofield, C., Chaudhuri, K. R., Carroll, C., Sharma, J. C.
, Pavese, N., Evans, J., Foltynie, T., Reichmann, H., Zurowska, L., Soares-Da-Silva, P. & Lees, A. (2022).
Opicapone in UK clinical practice: effectiveness, safety and cost analysis in patients with Parkinson's disease.
Neurodegenerative Disease Management,
12(2), 77-91.
https://doi.org/10.2217/nmt-2021-0057
Prevett, M. C., Cunningham, V. J.
, Brooks, D. J., Fish, D. R. & Duncan, J. S. (1994).
Opiate receptors in idiopathic generalised epilepsy measured with [11C]diprenorphine and positron emission tomography.
Epilepsy Research,
19(1), 71-77.
https://doi.org/10.1016/0920-1211(94)90090-6
Chang, N. H. S., Kumakura, Y.
, Møller, A., Linnet, J.
, Bender, D., Doudet, D. J., Vafaee, M. S.
& Gjedde, A. (2022).
On the learning of addictive behavior: Sensation-seeking propensity predicts dopamine turnover in dorsal striatum.
Brain Imaging and Behavior,
16(1), 355-365.
https://doi.org/10.1007/s11682-021-00509-5
Alstrup, A. K. O., Landau, A. M., Holden, J. E., Simonsen, M., Schacht, A. C.
, Jakobsen, S., Wegener, G., Hansen, A. K.
, Gjedde, A. & Doudet, D. (2011).
On the interpretation of PET binding data in brain: Effects of anesthesia and consideration of species differences. Abstract from World Molecular Imaging Congress (WMIC), San Diego, United States.
Pineda-Pardo, J. D. S. A., Sánchez-Ferro, Á., Monje, M. H. G.
, Pavese, N. & Obeso, J. A. (2022).
Onset pattern of nigrostriatal denervation in early Parkinson's disease.
Brain,
145(3), 1018-1028.
https://doi.org/10.1093/brain/awab378
Schrag, A., Rinne, J. O., Burn, D. J., Mathias, C. J., Marsden, C. D.
, Brooks, D. J. & Quinn, N. P. (1998).
Olivopontocerebellar atrophy and multiple system atrophy: Clinical follow-up of 10 patients studied with PET [4].
Annals of Neurology,
44(1), 151-152.
https://doi.org/10.1002/ana.410440133
Fjaeldstad, A., Kjaergaard, T., van Hartevelt, T. J.
, Moeller, A., Kringelbach, M. L. & Ovesen, T. (2015).
Olfactory screening: Validation of Sniffin' Sticks in Denmark.
Clinical Otolaryngology,
40(6), 545-550.
https://doi.org/10.1111/coa.12405
Doudet, D. J., Clark, C.
, Alstrup, A. K. O., Jakobsen, S., Gjedde, A.
, Wegener, G., Videbech, P.
& Landau, A. M. (2014).
Of Pig and Man: Analogy of response to electroconvulsive therapy (ECT): most do, a few don’t. Abstract from CINP World Congress, Vancouver, Canada.
Eskildsen, S., Iranzo, A.
, Stokholm, M., Staer, K., Ostergaard, K., Eroles, M.
, Otto, M., Svendsen, K., Pla, A., Vilas, D.
, Borghammer, P., Santamaria, J.
, Moller, A., Gaig, C.
, Brooks, D., Tolosa, E., Ostergaard, L.
& Pavese, N. (2019).
Occurrence of brain capillary dysfunction in patients with REM sleep behavior disorder. S786-S787. Abstract from International Congress of Parkinson's Disease and Movement Disorders, Nice, France.
Jeppesen, J., Otto, M., Frederiksen, Y., Hansen, A. K., Fedorova, T. D., Knudsen, K., Nahimi, A., Brooks, D. J., Borghammer, P. & Sommerauer, M. (2018).
Observations on muscle activity in REM sleep behavior disorder assessed with a semi-automated scoring algorithm.
Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology,
129(3), 541-547.
https://doi.org/10.1016/j.clinph.2017.12.029
Dagø, L., Bonde, C., Peters, D.
, Møller, A., Bomholt, S. F., Hartz, B. P., Meyer, M., Drejer, J. & Grønborg, M. (2002).
NS1231, a novel compound with neurotrophic-like effects in vitro and in vivo.
Neurochemical,
81, 17-24.
Tomasi, G., Edison, P., Bertoldo, A., Roncaroli, F., Singh, P., Gerhard, A., Cobelli, C.
, Brooks, D. J. & Turkheimer, F. E. (2008).
Novel reference region model reveals increased microglial and reduced vascular binding of11C-(R)-PK11195 in patients with Alzheimer's disease.
Journal of Nuclear Medicine,
49(8), 1249-1256.
https://doi.org/10.2967/jnumed.108.050583
Cumming, P., Danielsen, E. H., Vafaee, M., Faldborg, L., Steffensen, E., Sørensen, J. C., Gillings, N., Bender, D., Marthi, K., Andersen, F., Munk, O., Smith, D.
, Møller, A. & Gjedde, A. (2001).
Normalization of markers for dopamine innervation in striatum of MPTP-lesioned miniature pigs with intrastriatal grafts.
Acta Neurologica Scandinavica,
103, 309-315.
Kinnerup, M., Doppler, C., Farrher, E.
, Fedorova, T., Schaldemose, J.
, Knudsen, K., Isamail, R.
, Hansen, A., Staer, K., Fink, G., Shah, J.
, Brooks, D., Nahimi, A., Borghammer, P. & Sommerauer, M. (2020).
Noradrenergic terminal and locus coeruleus cell loss may be uncoupled in Parkinson's disease - a PET and MRI multi-modal imaging study.
Movement Disorders,
35(Suppl. S1), S251.
https://doi.org/10.1002/mds.28268
Doudet, D., Dyve, S., Olsen Alstrup, A. K.
, Jakobsen, S., Simonsen, M.
, Møller, A., Videbech, P.
, Wegener, G., Gjedde, A. & Landau, A. M. (2010).
Noradrenaline release: potential antidepressant mechanism of brain stimulation? NeuroImage.
Doudet, D., Dyve, S.
, Alstrup, A. K. O., Jakobsen, S., Simonsen, M.
, Møller, A., Videbech, P.
, Wegener, G., Gjedde, A. & Landau, A. M. (2010).
Noradrenaline release: potential antidepressant mechanism of brain stimulation.
NeuroImage, (1), 47.
Dyve, S.
, Landau, A. M., Alstrup, A. K. O., Jakobsen, S., Doudet, D.
& Gjedde, A. (2010).
Noradrenaline release explains effects of vagal nerve stimulation in pig brain in vivo. PET study with tracer [11C]yohimbine, an alpha 2 adrenoceptor antagonist. Poster session presented at American College of Neurophychopharmacology, Miami, United States.
Landau, A. M., Dyve, S.
, Alstrup, A. K. O., Møller, A., Simonsen, M.
, Jakobsen, S., Videbech, P.
, Wegener, G. & Doudet, D. (2010).
Noradrenaline release: a potential antidepressant mechanism of brain stimulation therapies. Abstract from OAK Meeting, København, Denmark.
Jost, S. T., Visser-Vandewalle, V., Rizos, A., Loehrer, P. A., Silverdale, M., Evans, J., Samuel, M., Petry-Schmelzer, J. N., Sauerbier, A., Gronostay, A., Barbe, M. T., Fink, G. R., Ashkan, K., Antonini, A., Martinez-Martin, P., Chaudhuri, K. R., Timmermann, L., Dafsari, H. S. & EUROPAR and the International Parkinson and Movement Disorders Society Non-Motor Parkinson’s Disease Study Group (2021).
Non-motor predictors of 36-month quality of life after subthalamic stimulation in Parkinson disease.
Parkinson's Disease,
7(1), Article 48.
https://doi.org/10.1038/s41531-021-00174-x
Vibholm, A. K.
, Landau, A. M., Møller, A., Jacobsen, J., Vang, K., Munk, O. L., Orlowski, D., Sorensen, J. C. H. & Brooks, D. J. (2021).
NMDA receptor ion channel activation detected in vivo with [18F]GE-179 PET after electrical stimulation of rat hippocampus.
Journal of Cerebral Blood Flow and Metabolism,
41(6), 1301-1312.
https://doi.org/10.1177/0271678X20954928
McGinnity, C. J., Koepp, M. J., Hammers, A., Barros, D. A. R., Pressler, R. M., Luthra, S. K., Jones, M. P. A., Trigg, W., Micallef, C., Symms, M. R.
, Brooks, D. J. & Duncan, J. S. (2015).
NMDA receptor binding in focal epilepsies.
Journal of Neurology, Neurosurgery & Psychiatry,
86(10), 1150-1157.
https://doi.org/10.1136/jnnp-2014-309897
Lillethorup, T. P., Glud, A. N., Alstrup, A. K. O., Mikkelsen, T. W., Nielsen, E. H. T., Zaer, H., Doudet, D. J.
, Brooks, D. J., Sørensen, J. C. H., Orlowski, D. & Landau, A. M. (2018).
Nigrostriatal proteasome inhibition impairs dopamine neurotransmission and motor function in minipigs.
Experimental Neurology,
303, 142-152.
https://doi.org/10.1016/j.expneurol.2018.02.005
Pavese, N., Khan, N. L., Scherfler, C., Cohen, L.
, Brooks, D. J., Wood, N. W., Bhatia, K. P., Quinn, N. P., Lees, A. J. & Piccini, P. (2009).
Nigrostriatal dysfunction in homozygous and heterozygous Parkin gene carriers: An18F-dopa PET progression study.
Movement Disorders,
24(15), 2260-2266.
https://doi.org/10.1002/mds.22817
Hu, M. T. M., Scherfler, C., Khan, N. L., Hajnal, J. V., Lees, A. J., Quinn, N., Wood, N. W.
& Brooks, D. J. (2006).
Nigral degeneration and striatal dopaminergic dysfunction in idiopathic and parkin-linked Parkinson's disease.
Movement Disorders,
21(3), 299-305.
https://doi.org/10.1002/mds.20702
Best, L., Ghadery, C.
, Pavese, N., Tai, Y. F. & Strafella, A. P. (2019).
New and Old TSPO PET Radioligands for Imaging Brain Microglial Activation in Neurodegenerative Disease.
Current Neurology and Neuroscience Reports,
19(5), Article 24.
https://doi.org/10.1007/s11910-019-0934-y
Grønborg, M., Johansen, T. E., Peters, D., Ahring, P. K., Drejer, J.
, Møller, A. & Jensen, L. H. (1999).
Neuroprotection by a novel compound, NS5211.
The Journal of Pharmacology and Experimental Therapeutics,
290, 348-353.
Kelsen, J., Larsen, M. H.
, Sørensen, J. C., Møller, A., Frøkiaer, J., Nielsen, S.
, Nyengaard, J. R., Mikkelsen, J. D. & Rønn, L. C. B. (2010).
Neuronal precursor cell proliferation in the hippocampus after transient cerebral ischemia: a comparative study of two rat strains using stereological tools.
Experimental & translational stroke medicine,
2, 8.
https://doi.org/10.1186/2040-7378-2-8
Wicks, P., Turner, M. R., Abrahams, S., Hammers, A.
, Brooks, D. J., Leigh, P. N. & Goldstein, L. H. (2008).
Neuronal loss associated with cognitive performance in amyotrophic lateral sclerosis: An (11C)-flumazenil PET study.
Amyotrophic Lateral Sclerosis,
9(1), 43-49.
https://doi.org/10.1080/17482960701737716
Bjarkam, C., Nielsen, M. S., Glud, A. N., Rosendal, F., Mogensen, P.
, Bender, D., Doudet, D.
, Møller, A. & Sørensen, J. C. H. (2008).
Neuromodulation in a minipig MTTP model of Parkinson disease.
British Journal of Neurosurgery,
22/1, 9-12.
Bjarkam, C. R., Nielsen, M. S.
, GLUD, AN., Rosendal, F., Mogensen, P.
, Bender, D., Doudet, D.
, Møller, A. & Sørensen, J. C. (2008).
Neuromodulation in a minipig MPTP model of Parkinson disease.
British Journal of Neurosurgery,
22 Suppl 1, S9-12.
https://doi.org/10.1080/02688690802448285
Xing, Y., Sapuan, A. H., Martín-Bastida, A., Naidu, S., Tench, C., Evans, J., Sare, G., Schwarz, S. T., Al-bachari, S., Parkes, L. M., Kanavou, S., Raw, J., Silverdale, M., Bajaj, N.
, Pavese, N., Burn, D., Piccini, P., Grosset, D. G. & Auer, D. P. (2022).
Neuromelanin-MRI to Quantify and Track Nigral Depigmentation in Parkinson's Disease: A Multicenter Longitudinal Study Using Template-Based Standardized Analysis.
Movement Disorders,
37(5), 1028-1039.
https://doi.org/10.1002/mds.28934
Cai, X. L., Wang, Y. M., Wang, Y., Zhou, H. Y., Huang, J., Wang, Y., Lui, S. S. Y.
, Møller, A., Hung, K. S. Y., Mak, H. K. F., Sham, P. C., Cheung, E. F. C. & Chan, R. C. K. (2021).
Neurological Soft Signs Are Associated with Altered Cerebellar-Cerebral Functional Connectivity in Schizophrenia.
Schizophrenia Bulletin,
47(5), 1452-1462.
https://doi.org/10.1093/schbul/sbaa200
Leng, F., Hinz, R., Gentleman, S., Hampshire, A., Dani, M.
, Brooks, D. J. & Edison, P. (2023).
Neuroinflammation is independently associated with brain network dysfunction in Alzheimer's disease.
Molecular Psychiatry,
28(3), 1303-1311.
https://doi.org/10.1038/s41380-022-01878-z
Heneka, M. T., Carson, M. J., El Khoury, J., Landreth, G. E., Brosseron, F., Feinstein, D. L., Jacobs, A. H., Wyss-Coray, T., Vitorica, J., Ransohoff, R. M., Herrup, K., Frautschy, S. A., Brown, G. C., Verkhratsky, A., Yamanaka, K., Koistinaho, J., Latz, E., Halle, A., Petzold, G. C. ... Kummer, M. P. (2015).
Neuroinflammation in Alzheimer's disease.
Lancet Neurology,
14(4), 388-405.
Leng, F., Hinz, R., Gentleman, S.
, Brooks, D. J. & Edison, P. (2021).
Neuroinflammation, functional connectivity and structural network integrity in the Alzheimer's spectrum.
Alzheimer's & dementia : the journal of the Alzheimer's Association,
17(S3), e055970.
https://doi.org/10.1002/alz.055970
Terkelsen, M. H., Klæstrup, I. H., Hvingelby, V., Lauritsen, J., Pavese, N. & Romero-Ramos, M. (2022).
Neuroinflammation and Immune Changes in Prodromal Parkinson’s Disease and Other Synucleinopathies.
Journal of Parkinson's Disease,
12(s1), S149-S163.
https://doi.org/10.3233/JPD-223245
Metaxas, A., Anzalone, M., Vaitheeswaran, R., Petersen, S.
, Landau, A. M. & Finsen, B. (2019).
Neuroinflammation and amyloid-beta 40 are associated with reduced serotonin transporter (SERT) activity in a transgenic model of familial Alzheimer's disease.
Alzheimer's Research & Therapy,
11(1), Article 38.
https://doi.org/10.1186/s13195-019-0491-2